All deployments

PharmaDeployment record

Insilico Medicine

AI for drug candidate selection

StageLive

320trial enrollment

Function
drug development
drug candidate
rentosertib
trial phase
Phase 3
first patient dosed
September 2026
trial duration
52 weeks
Date
Sep 1, 2026

Source story

AI Could Make Pharma’s Drug Testing Bottleneck Worse

Insilico Medicine company profile →Pharma desk →

MachineCon USA · from AIM Media House

Where enterprise AI is decided

An invitation-led day for the CIOs, CDOs and Chief AI Officers who own enterprise AI strategy.

  • New York5th edition · 583 Park Avenue
  • Dallas1st edition

Register for MachineCon USASee MachineCon USA →

  • Keynote on the main stage, MachineCon New York 2025
  • AI150 award winners on stage, MachineCon New York 2025
  • At the tables, MachineCon New York 2025
  • Networking, MachineCon New York 2025